Sivik Global Healthcare LLC Increases Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Sivik Global Healthcare LLC raised its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 7.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 150,000 shares of the health services provider’s stock after acquiring an additional 10,000 shares during the quarter. Select Medical accounts for approximately 1.5% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 28th biggest position. Sivik Global Healthcare LLC’s holdings in Select Medical were worth $2,828,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Kingsview Wealth Management LLC purchased a new stake in shares of Select Medical during the 3rd quarter valued at about $1,927,000. JPMorgan Chase & Co. boosted its holdings in Select Medical by 9.7% in the third quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after purchasing an additional 36,905 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Select Medical in the 3rd quarter worth approximately $1,592,000. Argent Capital Management LLC raised its stake in Select Medical by 79.8% during the 4th quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock valued at $1,039,000 after buying an additional 24,471 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Select Medical by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after buying an additional 46,880 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Down 3.6 %

Shares of SEM stock opened at $19.65 on Thursday. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 9.20, a PEG ratio of 0.65 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company’s fifty day moving average price is $20.61 and its 200-day moving average price is $30.16. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the business earned $0.46 earnings per share. The business’s revenue was up 5.7% on a year-over-year basis. Sell-side analysts expect that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on SEM shares. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Monday. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada boosted their price target on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, UBS Group reduced their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $39.50.

Insider Buying and Selling

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.